VirBio (VIR)
Develops immune-based medicines for chronic hepatitis delta, solid tumors, and HIV cure research.
$11.33
vs last close+0.45 (+4.14%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 86.99% | 147.21M shares | |
|---|---|---|---|
| 246 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 11.90% | 20.14M shares | |
| 15 holders · as of Aug 12, 2026 | |||
| Strategic holders | 13.66% | 23.12M shares | |
| 3 holders · as of Dec 3, 2025 | |||
| Adds to | 112.55% | ||
169.22M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
These groups come from separate filings that can overlap, so they add to 112.55%; nothing is left for Other.
13F, as of Jun 30, 2026
246 holders · 147.21M shares · 33 new positions · 128 increased · 75 reduced · 48 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 20.68M | 12.22% | +2.68M | Aug 7, 2026 |
| Arch Venture Management, LLC | 12.69M | 7.50% | −222.5K | Aug 14, 2026 |
| Vanguard Portfolio Management LLC | 11.50M | 6.79% | +2.28M | Aug 13, 2026 |
| SB Investment Advisers (UK) Ltd | 10.95M | 6.47% | 0 | Aug 14, 2026 |
| State Street Corp | 9.96M | 5.89% | +2.82M | Aug 7, 2026 |
| GSK PLC | 8.55M | 5.05% | 0 | Aug 13, 2026 |
| Vanguard Capital Management LLC | 6.39M | 3.78% | +1.01M | Aug 13, 2026 |
| Point72 Asset Management, L.P. | 5.67M | 3.35% | +3.71M | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 10.80% | 14.83M | 13G | Apr 28, 2025 |
| Robert Nelsenincl. ARCH Venture Partners IX Overage, L.P., Clinton Bybee +5 more | 8.50% | 13.53M | 13D | Mar 3, 2026 |
| SB Investment Advisers (UK) Limited | 6.50% | 10.95M | 13G | May 15, 2026 |
| State Street Corporation | 5.90% | 9.96M | 13G | Aug 7, 2026 |
| Vanguard Portfolio Management | 5.79% | 9.26M | 13G | Apr 29, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jun 1, 2026 | Brent Sabatiniofficer: SVP, Chief Accounting Officer | Sale | 379 | $9.45 | 61,902 |
| Jun 1, 2026 | Janet Napolitanodirector | Sale | 3,200 | $9.45 | 21,216 |
| May 1, 2026 | Vicki L. Satodirector | Sale | 22,000 | $10.05 | 1,078,391 |
| Apr 6, 2026 | Marianne de Backerdirector, officer: President and CEO | Sale | 72,559 | $9.16 | 948,145 |
| Apr 1, 2026 | Vicki L. Satodirector | Sale | 22,000 | $9.07 | 1,100,391 |
| Mar 23, 2026 | Brent Sabatiniofficer: SVP, Chief Accounting Officer | Sale | 7,711 | $9.12 | 61,902 |
| Mar 2, 2026 | Vicki L. Satodirector | Sale · 2 lots | 22,000 | $9.51 | 1,122,391 |
| Feb 24, 2026 | Marianne de Backerdirector, officer: Chief Executive Officer | Sale | 14,762 | $9.53 | 1,020,704 |
| Feb 25, 2026 | Vanina de Verneuilofficer: EVP, General Counsel, Corp Sec | Sale | 13,700 | $9.82 | 112,982 |
| Feb 24, 2026 | Vanina de Verneuilofficer: EVP, General Counsel, Corp Sec | Sale | 3,117 | $9.53 | 126,682 |
House and Senate disclosures
Not reported.